Your browser doesn't support javascript.
loading
Perspective: 4ß-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A.
Mao, Jialin; Martin, Iain; McLeod, James; Nolan, Gail; van Horn, Robert; Vourvahis, Manoli; Lin, Yvonne S.
Affiliation
  • Mao J; a Drug Metabolism and Pharmacokinetics , Genentech , South San Francisco , CA , USA.
  • Martin I; b Pharmacokinetics, Pharmacodynamics and Drug Metabolism , Merck , Boston , MA , USA.
  • McLeod J; c Drug Development , Galleon Pharmaceuticals , Horsham , PA , USA.
  • Nolan G; d Drug Metabolism and Pharmacokinetics , GlaxoSmithKline , Hertfordshire , UK.
  • van Horn R; e Translational Medicine and Early Development , Sanofi , Bridgewater , NJ , USA.
  • Vourvahis M; f Clinical Pharmacology , Pfizer , New York , NY , USA.
  • Lin YS; g Department of Pharmaceutics , University of Washington , Seattle , WA , USA.
Drug Metab Rev ; 49(1): 18-34, 2017 02.
Article in En | MEDLINE | ID: mdl-27718639
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Midazolam / Hydrocortisone / Cytochrome P-450 CYP3A / Hydroxycholesterols Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Drug Metab Rev Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Midazolam / Hydrocortisone / Cytochrome P-450 CYP3A / Hydroxycholesterols Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Drug Metab Rev Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom